Envista Holdings Corporation (NYSE:NVST) Receives $29.31 Consensus Target Price from Analysts

Envista Holdings Corporation (NYSE:NVST) has earned a consensus recommendation of “Moderate Buy” from the sixteen analysts that are presently covering the stock, Marketbeat.com reports. Nine equities research analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $29.3077.

A number of equities analysts have recently weighed in on the company. Weiss Ratings raised Envista from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 6th. Evercore reissued an “outperform” rating and issued a $33.00 target price on shares of Envista in a research note on Thursday, May 7th. JPMorgan Chase & Co. lifted their price target on shares of Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Wall Street Zen raised shares of Envista from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 22nd. Finally, BMO Capital Markets assumed coverage on shares of Envista in a research note on Wednesday, July 8th. They set a “market perform” rating and a $27.00 price objective on the stock.

Insiders Place Their Bets

In other Envista news, SVP Mischa Reis sold 8,000 shares of the business’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the completion of the transaction, the senior vice president directly owned 27,321 shares in the company, valued at approximately $751,327.50. The trade was a 22.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.99% of the company’s stock.

Hedge Funds Weigh In On Envista

Large investors have recently added to or reduced their stakes in the business. GSA Capital Partners LLP purchased a new position in shares of Envista during the 2nd quarter worth about $2,039,000. Pzena Investment Management LLC purchased a new position in Envista during the second quarter worth approximately $30,494,000. Dimensional Fund Advisors LP raised its stake in Envista by 1.6% during the first quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock worth $248,130,000 after purchasing an additional 152,488 shares during the period. SummitTX Capital L.P. acquired a new position in shares of Envista in the 1st quarter valued at $4,268,000. Finally, Principal Financial Group Inc. boosted its holdings in shares of Envista by 36.8% in the 1st quarter. Principal Financial Group Inc. now owns 483,983 shares of the company’s stock valued at $12,279,000 after purchasing an additional 130,237 shares during the last quarter.

Envista Stock Performance

Shares of NVST opened at $27.15 on Friday. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. The stock has a market cap of $4.36 billion, a P/E ratio of 46.81, a PEG ratio of 1.31 and a beta of 0.86. The company has a 50-day moving average of $27.12 and a two-hundred day moving average of $26.38. Envista has a 12-month low of $18.77 and a 12-month high of $30.42.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The business had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. During the same period in the prior year, the business earned $0.26 earnings per share. The company’s quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, research analysts predict that Envista will post 1.53 EPS for the current fiscal year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.